Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John I Bell

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|December 8, 2021
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United KingdomA Sarah Walker, Karina-Doris Vihta, Owen Gethings, et al.
Nature Communications|May 16, 2023
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UKJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
The Lancet Regional Health. Europe|December 20, 2021
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillanceEmma Pritchard, Joel Jones, Karina-Doris Vihta, et al.
Nature Medicine|February 15, 2022
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Koen B Pouwels, Nicole Stoesser, et al.
Nature Communications|June 29, 2022
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infectionJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|December 8, 2021
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United KingdomA Sarah Walker, Karina-Doris Vihta, Owen Gethings, et al.
Nature Communications|May 16, 2023
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UKJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
The Lancet Regional Health. Europe|December 20, 2021
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillanceEmma Pritchard, Joel Jones, Karina-Doris Vihta, et al.
Nature Medicine|February 15, 2022
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Koen B Pouwels, Nicole Stoesser, et al.
Nature Communications|June 29, 2022
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infectionJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Pageof 6